Related Experiment Video
Updated: Mar 29, 2026

07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
5.4K
Solving the Problem of Nonadherence to Immunotherapy.
Bruce G Bender1, Richard F Lockey2
1Center for Health Promotion, National Jewish Health, 1400 Jackson Street, Denver, CO 80206, USA.
Immunology and Allergy Clinics of North America
|December 1, 2015
Summary
Allergen immunotherapy (AIT) adherence is low, with most patients stopping treatment within a year. Improving patient-centered communication strategies can enhance adherence and treatment success.
Area of Science:
- Allergy and Immunology
- Patient Adherence Research
Background:
- Allergen immunotherapy (AIT) modifies allergic responses but suffers from poor patient adherence.
- Fewer than 10% of patients complete a full AIT course, with most discontinuing within the first year.
Purpose of the Study:
- To explore emerging interventions for improving AIT adherence.
- To leverage insights from adherence interventions in other chronic conditions to guide allergists.
Main Methods:
- Review of adherence interventions in chronic conditions.
- Emphasis on evidence-based communication strategies.
Main Results:
- Patient-centered care, motivational interviewing, and shared decision-making are crucial.
- Building trust and understanding patient priorities are key to improving adherence.
Conclusions:
- Interventions focusing on communication can enhance AIT adherence.
- Involving patients in decision-making is vital for successful AIT completion and outcomes.
Related Concept Videos
Tumor Immunotherapy
2.2K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
Cell-mediated Immune Responses
86.3K
Overview
86.3K
Immunodeficiency Diseases
3.1K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
3.1K
Treatment Resistent Cancers
1.5K
1.5K
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Pulmonary Tuberculosis I
1.4K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.4K

